195 related articles for article (PubMed ID: 18083234)
21. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Shih HM; Chang CC; Kuo HY; Lin DY
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a C-Terminal SUMO-Interacting Motif Present in Select PIAS-Family Proteins.
Lussier-Price M; Mascle XH; Cappadocia L; Kamada R; Sakaguchi K; Wahba HM; Omichinski JG
Structure; 2020 May; 28(5):573-585.e5. PubMed ID: 32348746
[TBL] [Abstract][Full Text] [Related]
23. Mapping DNA-binding domains of the autoimmune regulator protein.
Purohit S; Kumar PG; Laloraya M; She JX
Biochem Biophys Res Commun; 2005 Feb; 327(3):939-44. PubMed ID: 15649436
[TBL] [Abstract][Full Text] [Related]
24. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
25. PIAS1 interacts with the KRAB zinc finger protein, ZNF133, via zinc finger motifs and regulates its transcriptional activity.
Lee SJ; Lee JR; Hahn HS; Kim YH; Ahn JH; Bae CD; Yang JM; Hahn MJ
Exp Mol Med; 2007 Aug; 39(4):450-7. PubMed ID: 17934332
[TBL] [Abstract][Full Text] [Related]
26. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
27. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.
Kotaja N; Aittomäki S; Silvennoinen O; Palvimo JJ; Jänne OA
Mol Endocrinol; 2000 Dec; 14(12):1986-2000. PubMed ID: 11117529
[TBL] [Abstract][Full Text] [Related]
28. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
29. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.
Jackson PK
Genes Dev; 2001 Dec; 15(23):3053-8. PubMed ID: 11731472
[No Abstract] [Full Text] [Related]
30. Autoimmune regulator: from loss of function to autoimmunity.
Pitkänen J; Peterson P
Genes Immun; 2003 Jan; 4(1):12-21. PubMed ID: 12595897
[TBL] [Abstract][Full Text] [Related]
31. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
32. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
Palvimo JJ
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1405-8. PubMed ID: 18031232
[TBL] [Abstract][Full Text] [Related]
33. PIAS1 interacts with FLASH and enhances its co-activation of c-Myb.
Alm-Kristiansen AH; Lorenzo PI; Molværsmyr AK; Matre V; Ledsaak M; Sæther T; Gabrielsen OS
Mol Cancer; 2011 Feb; 10():21. PubMed ID: 21338522
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
35. The effect of human GATA4 gene mutations on the activity of target gonadal promoters.
Bouchard MF; Taniguchi H; Viger RS
J Mol Endocrinol; 2009 Feb; 42(2):149-60. PubMed ID: 19008335
[TBL] [Abstract][Full Text] [Related]
36. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity.
Wang J; Feng XH; Schwartz RJ
J Biol Chem; 2004 Nov; 279(47):49091-8. PubMed ID: 15337742
[TBL] [Abstract][Full Text] [Related]
37. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8.
Tang Z; El Far O; Betz H; Scheschonka A
J Biol Chem; 2005 Nov; 280(46):38153-9. PubMed ID: 16144832
[TBL] [Abstract][Full Text] [Related]
38. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the dual-function transcription factor Sp3 by SUMO.
Valin A; Gill G
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1393-6. PubMed ID: 18031229
[TBL] [Abstract][Full Text] [Related]
40. The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers.
Estruch SB; Graham SA; Deriziotis P; Fisher SE
Sci Rep; 2016 Feb; 6():20911. PubMed ID: 26867680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
